Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Medpace Holdings Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Medpace Holdings Inc. May 19, 202356.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 30, 2026 | Medpace Holdings Inc. | Option exercise | +36 | — | — |
| Aug 19, 2026 | Medpace Holdings Inc. | Open-market sale | −5,000 | $608.63 | $3,043,150 |
| Jun 30, 2026 | Medpace Holdings Inc. | Option exercise | +36 | — | — |
| Mar 31, 2026 | Medpace Holdings Inc. | Option exercise | +36 | — | — |
| Feb 13, 2026 | Medpace Holdings Inc. | Option exercise | +6,472 | $54.99 | $355,895 |
| Dec 31, 2025 | Medpace Holdings Inc. | Option exercise | +62 | — | — |
| Sep 30, 2025 | Medpace Holdings Inc. | Option exercise | +62 | — | — |
| Jun 30, 2025 | Medpace Holdings Inc. | Option exercise | +62 | — | — |
| Mar 31, 2025 | Medpace Holdings Inc. | Option exercise | +63 | — | — |
| Feb 24, 2025 | Medpace Holdings Inc. | Option exercise | +8,127 | $42.62 | $346,373 |
| Feb 24, 2025 | Medpace Holdings Inc. | Open-market sale | −4,003 | $345.59 | $1,383,397 |
| Dec 31, 2024 | Medpace Holdings Inc. | Option exercise | +78 | — | — |
| Sep 30, 2024 | Medpace Holdings Inc. | Option exercise | +78 | — | — |
| Jun 30, 2024 | Medpace Holdings Inc. | Option exercise | +78 | — | — |
| Mar 31, 2024 | Medpace Holdings Inc. | Option exercise | +79 | — | — |
Questions about Brian T. Carley
What boards is Brian T. Carley on?
Brian T. Carley sits on the board of Medpace Holdings Inc.
How long has Brian T. Carley served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.